Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT04539964
PHASE3

Vagus Nerve Stimulation for Moderate to Severe Rheumatoid Arthritis

Sponsor: SetPoint Medical Corporation

View on ClinicalTrials.gov

Summary

The RESET-RA study will assess the safety and efficacy of the SetPoint System (study device) for the treatment of adult patients with active, moderate to severe rheumatoid arthritis who have had an inadequate response or intolerance to biologic or targeted synthetic Disease-Modifying Anti-Rheumatic Drugs (DMARDs). The study device contains a miniaturized stimulator (implant) that is surgically placed under general anesthesia on the vagus nerve through a small incision on the left side of the neck (implant procedure). The study will enroll up to 250 subjects at up to 45 sites. All eligible subjects will undergo the implant procedure. Half of the subjects will receive active stimulation (treatment) and the other half will receive non-active stimulation (control). After completing primary endpoint assessments at Week 12, there will be a one-way crossover of control subjects to active stimulation and a 252-week open-label follow-up with all subjects (treatment and control) receiving active stimulation to evaluate long-term safety.

Official title: Vagus Nerve Stimulation Using the SetPoint System for Moderate to Severe Rheumatoid Arthritis: The RESET-RA Study

Key Details

Gender

All

Age Range

22 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

243

Start Date

2021-01-11

Completion Date

2027-10

Last Updated

2026-02-10

Healthy Volunteers

No

Interventions

PROCEDURE

Implant Procedure

The SetPoint System (study device) contains a miniaturized stimulator (implant) that is surgically implanted inside the left side of the neck on the vagus nerve (implant procedure). All eligible subjects will undergo the surgery under general anesthesia in outpatient settings.

DRUG

Conventional Synthetic DMARD

All subjects will continue to take at least one type of conventional synthetic DMARD at the same stable dose as for 4 weeks prior to consent

DEVICE

Active stimulation

Active stimulation for 1 min once per day

DEVICE

Non-active stimulation

Non-active stimulation for 1 min once per day

Locations (42)

Arizona Arthritis ans Rheumatology Research, PPLC

Mesa, Arizona, United States

Arizona Arthritis Rheumatology & Research, PLLC

Phoenix, Arizona, United States

Arizona Arthritis & Rheumatology Research, PLLC

Tucson, Arizona, United States

Medvin Clinical Research

Covina, California, United States

Inland Rheumatology Clinical Trials

Upland, California, United States

Medvin Clinical Research

Whittier, California, United States

The Arthritis & Rheumatology Clinic of Northern Colorado

Fort Collins, Colorado, United States

Stamford Therapeutics Consortium

Stamford, Connecticut, United States

Delaware Arthritis

Lewes, Delaware, United States

Arthritis & Rheumatic Disease Specialties

Aventura, Florida, United States

HARAC Research Corporation

Avon Park, Florida, United States

RecioMed Clinical Research Network, Inc.

Boynton Beach, Florida, United States

Bay Area Rheumatology

Clearwater, Florida, United States

IRIS Research and Development

Plantation, Florida, United States

Augusta University

Augusta, Georgia, United States

Parris and Associates Rheumatology

Lawrenceville, Georgia, United States

Northwestern University

Chicago, Illinois, United States

Willow Rheumatology and Wellness PLLC

Willowbrook, Illinois, United States

Massachusetts General Hospital Division of Rheumatology, Allergy, and Immunology

Boston, Massachusetts, United States

June DO, PC

Lansing, Michigan, United States

Saint Paul Rheumatology, P.A.

Eagan, Minnesota, United States

Kansas City Physician Partners

Kansas City, Missouri, United States

West County Rheumatology

St Louis, Missouri, United States

Physician Research Collaboration, LLC

Lincoln, Nebraska, United States

Albuquerque Center for Rheumatology

Albuquerque, New Mexico, United States

Long Island Regional Arthritis & Osteoporosis Care

Babylon, New York, United States

Arthritis & Osteoporosis Consultants Of The Carolinas

Charleston, North Carolina, United States

DJL Clinical Research

Charlotte, North Carolina, United States

Health Research of Oklahoma, PLLC

Oklahoma City, Oklahoma, United States

Lehigh Valley Health Network

Allentown, Pennsylvania, United States

University of Pennsylvania Medical Center

Philadelphia, Pennsylvania, United States

Arthritis & Rheumatology Research Institute, PLLC

Allen, Texas, United States

Austin Regional Clinic

Austin, Texas, United States

Tekton Research

Austin, Texas, United States

Central Texas Rheumatology Associates

Austin, Texas, United States

Precision Comprehensive Clinical Research Solutions

Colleyville, Texas, United States

Biopharma Informatic

Houston, Texas, United States

Southwest Rheumatology Research LLC

Mesquite, Texas, United States

Clinical Trials of Texas, Inc

San Antonio, Texas, United States

Annapolis Rheumatology

Fairfax, Virginia, United States

Sound Clinical Research, LLC

Bothell, Washington, United States

West Virginia University

Morgantown, West Virginia, United States